These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8324143)

  • 1. A new potent beta-lactamase inhibitor, BRL 42715, with inherent activity against Bacteroides fragilis group strains.
    Aldridge KE
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S335-8. PubMed ID: 8324143
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of beta-lactamases in clinical isolates of Bacteroides.
    Eley A; Greenwood D
    J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.
    Bandoh K; Ueno K; Watanabe K; Kato N
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S382-6. PubMed ID: 8324152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of beta-lactamases in the Bacteroides fragilis group].
    Martin C; Dubreuil L; Sedallian A; Romond C
    Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
    Aldridge KE; Henderberg A; Sanders CV
    J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antimicrobial activity of old and new beta-lactams against cefoxitin-resistant Bacteroides fragilis group isolates by beta-lactamase inhibitors.
    Aldridge KE; Henderberg A; Sanders CV
    J Antimicrob Chemother; 1990 May; 25(5):873-5. PubMed ID: 2373670
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.
    Dornbusch K; Olsson-Lijequist B; Nord CE
    J Antimicrob Chemother; 1980 Mar; 6(2):207-16. PubMed ID: 6966626
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
    O'Keefe JP; Venezio FR; DiVincenzo CA; Shatzer KL
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2002-4. PubMed ID: 3439807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.
    Cornick NA; Cuchural GJ; Snydman DR; Jacobus NV; Iannini P; Hill G; Cleary T; O'Keefe JP; Pierson C; Finegold SM
    J Antimicrob Chemother; 1990 Jun; 25(6):1011-9. PubMed ID: 2370237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial resistance of strains of the Bacteroides fragilis group isolated from the intestinal tract of children and adults in Brazil.
    Avelar KE; Vieira JM; Antunes LC; Lobo LA; Antunes EN; Domingues RM; Ferreira MC
    Int J Antimicrob Agents; 2001 Aug; 18(2):129-34. PubMed ID: 11516935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.
    Dubreuil L; Breuil J; Dublanchet A; Sedallian A
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1094-9. PubMed ID: 1295764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of four penicillin/beta-lactamase inhibitor combinations against cefoxitin-susceptible and cefoxitin-resistant Bacteroides fragilis isolates.
    Barry AL; Fuchs PC
    J Antimicrob Chemother; 1991 Feb; 27(2):243-4. PubMed ID: 2055814
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis.
    Mastrantonio P; Spigaglia P; Sebastianelli A
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):475-80. PubMed ID: 7957267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newer beta-lactam agents and the Bacteroides fragilis group.
    Cuchural GJ
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):51S-55S. PubMed ID: 2041832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR; Spangler SK; Appelbaum PC
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of beta-lactamase and the permeability barrier on the activity of cephalosporins against members of the Bacteroides fragilis group.
    Malouin F; Lamothe F
    Can J Microbiol; 1987 Mar; 33(3):262-6. PubMed ID: 3105858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of anaerobic bacteria to beta-lactam antibiotics in the United States.
    Johnson CC
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S371-6. PubMed ID: 8324150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-kill studies of the activity of temafloxacin against four strains of Bacteroides.
    Brown WJ; Moosavi S
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S355-6. PubMed ID: 8391863
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors contributing to resistance to beta-lactam antibiotics in Bacteroides fragilis.
    Olsson B; Dornbusch K; Nord CE
    Antimicrob Agents Chemother; 1979 Feb; 15(2):263-8. PubMed ID: 426517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of beta-lactamases from clinical isolates of Bacteroides species.
    Edwards R; Greenwood D
    J Med Microbiol; 1992 Feb; 36(2):89-95. PubMed ID: 1740789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.